Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Evotec, a developer of novel small molecule drugs with operational sites in Europe and Asia, has collaborated with ChemBridge to further enhance its screening library.
Subscribe to our email newsletter
San Diego-based ChemBridge is a global discovery chemistry company providing small molecule screening compound libraries, specialty building blocks for organic synthesis and custom chemistry services.
Through this collaboration, Evotec will increase its high throughput screening collection through the addition of initially 110,000 diverse and lead-like compounds from the ChemBridge Library Collection.
These new compounds complement the chemical diversity of Evotec’s existing collection and will further enhance the quality of the hits provided to its partners.